Tango Therapeutics
Presence
Tango Therapeutics is one of the...
Tango Therapeutics is a company listed under the stock ticker TNGX (US).
Executives
View the org chart displaying its 23 main executives
Most searched biographies at Tango Therapeutics
- Barbara Weber, Chief Executive Officer and Director
- Mace Rothenberg, Director
- Malte Peters, Director
Popular executive movements at Tango Therapeutics
- Kanishka Pothula has joined the company as Director (posted on November 9 2023).
- John Ketchum has joined the company as Director (posted on August 30 2023).
Create your alert
to follow the executive moves at Tango Therapeutics.
Biotechnology
Tango Therapeutics has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
- Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Tango Therapeutics
- Tango Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference | Tango Therapeutics, Inc
- Tango Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes | Tango Therapeutics, Inc
- Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference | Tango Therapeutics, Inc
- Tango Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights | Tango Therapeutics, Inc
- Tango Therapeutics to Participate in the Guggenheim Synthetic Lethality Day 2022 | Tango Therapeutics, Inc
- Tango Therapeutics to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference
- Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies
- Tango Therapeutics Appoints Mace Rothenberg, MD, and Lesley Ann Calhoun, CPA, to Board of Directors
- Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration
- Tango Therapeutics Announces $50 Million Equity Financing
- View more press releases Close
Social media about Tango Therapeutics
- Tango Therapeutics on Wikipedia, Google News & Yahoo Finance
- Tango Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Barbara Weber 
Call Tango Therapeutics at +1 857...
